Progressive hepatic mitochondrial dysfunction in premanifest Huntington's disease. Evidence for divergent effects of neurodegeneration in Huntington's disease on attentional selection and neural plasticity: implications for excitotoxicity. Impaired motor speech performance in Huntington's disease. Oral and dental health in Huntington's disease - an observational study. BMC Neurol. Action selection in a possible model of striatal medium spiny neuron dysfunction: behavioral and EEG data in a patient with benign hereditary chorea. J Mol Med Berl. Clinical utility gene card for: Huntington's disease.
Eur J Hum Genet. Diadochokinetic movements differ between patients with Huntington's disease and controls. Suicidal ideation in a European Huntington's disease population. J Affect Disord. CNR1 variation is associated with the age at onset in Huntington disease. Eur J Med Genet. A novel cognitive-neurophysiological state biomarker in premanifest Huntington's disease validated on longitudinal data. Sci Rep. Better global and cognitive functioning in choreatic versus hypokinetic-rigid Huntington's disease.
Hepatic mitochondrial dysfunction in manifest and premanifest Huntington disease. Mentalizing in preclinical Huntington's disease: an fMRI study using cartoon picture stories. Brain Imaging Behav. Collaborator A randomized, double-blind, placebo-controlled study of latrepirdine in patients with mild to moderate Huntington disease. JAMA Neurol. Faster perceptual learning through excitotoxic neurodegeneration.
Curr Biol. Brain activation and functional connectivity in premanifest Huntington's disease during states of intrinsic and phasic alertness. Hum Brain Mapp. Default-mode network changes in preclinical Huntington's disease. Functional and structural MRI biomarkers to detect pre-clinical neurodegeneration. Curr Alzheimer Res. Mechanisms mediating parallel action monitoring in fronto-striatal circuits. Altered ventral striatal activation during reward and punishment processing in premanifest Huntington's disease: a functional magnetic resonance study.
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Teaching Video NeuroImages: spinal and bulbar muscular atrophy mimicking essential tremor. Chorein-sensitive polymerization of cortical actin and suicidal cell death in choreaacanthocytosis. Placebo effect characteristics observed in a single, international, longitudinal study in Huntington's disease.
No evidence of impaired gastric emptying in early Huntington's Disease. PLoS Curr. Hepatic mitochondrial dysfunction in Friedreich ataxia. Pridopidine for the treatment of motor function in patients with Huntington's disease MermaiHD : a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Neurol. NMDA receptor gene variations as modifiers in Huntington disease: a replication study. Music perception and movement deterioration in Huntington's disease. On the role of fronto-striatal neural synchronization processes for response inhibition—evidence from ERP phase-synchronization analyses in pre-manifest Huntington's disease gene mutation carriers.
Mol Neurodegener. Magnetic resonance perfusion imaging of resting-state cerebral blood flow in preclinical Huntington's disease. J Cereb Blood Flow Metab. Post pump chorea in a year-old male. Neurol Sci. Depression in patients with Huntington disease correlates with alterations of the brain stem raphe depicted by transcranial sonography. J Neurol Neurosurg Psychiatry. Looking for new cardsets? Go to our Store.
Looking for new people? Use the search function on your friends page. Contact Your Name:. Your e-mail-address:. Please wait Downtime for Maintenance in: Days. Empty trash Do you really want to empty the trash? The flashcards will be irrecovably deleted. Empty Cancel. Categories Select categories. Convert to Html. Possibly this is helpful at problems with special characters. Multiple new cards Number of new cards:. Normal cards. Multiple choice cards with each answers. Deleting cards Move the selected cards into the trash? Manage categories Categories:. Categories Select category.
Move Move the cards to a different cardset. Select target cardset:. Copy Copy the cards to a different cardset. Index Move the cards to a different position in the fixed order. Report a copyright violation If you are sure that someone's or your copyright has been violated by the author of this card by publishing your content, please tell us. Recommend cardset Recommend the cardset. National Cooperative Crohn's Disease Study: adverse reactions to study drugs.
A comparison of budesonide with prednisolone for active Crohn's disease. Budesonide for induction of remission in Crohn's disease. Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn's disease. Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients. Serious infection and mortality in patients with Crohn's disease: more than 5 years of followup in the TREAT registry. Risk factors for opportunistic infections in patients with inflammatory bowel disease.
Gastroenterology ; — Heruntergeladen von: University of Pennsylvania Libraries. Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study. Effect of cigarette smoking on recurrence of Crohn's disease. Disease activity courses in a regional cohort of Crohn's disease patients.
Overall and cause-specific mortality in Crohn's disease: a meta-analysis of population-based studies. Predictors of Crohn's disease. Predictors of severe Crohn's disease. Predictive factors for an uncomplicated long-term course of Crohn's disease: a retrospective analysis. Early administration of azathioprine vs conventional management of Crohn's Disease: a randomized controlled trial. Early azathioprine therapy is no more effective than placebo for newly diagnosed Crohn's disease. Defective acute inflammation in Crohn's disease: a clinical investigation. Unravelling the pathogenesis of inflammatory bowel disease.
Treatment of active Crohn's disease with recombinant human granulocyte-macrophage colony-stimulating factor. Sargramostim for active Crohn's disease. Ageing and infection. The Lancet infectious diseases ; 2: — Nikolich-Zugich J. T cell aging: naive but not young. Aging and innate immunity. Immunity ; — Weng NP. Aging of the immune system: how much can the adaptive immune system adapt?
The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in patients. Predictors of infection in rheumatoid arthritis. Arthritis Rheum ; — Chandra RK. Nutrition, immunity and infection: from basic knowledge of dietary manipulation of immune responses to practical application of ameliorating suffering and improving survival. Effect of vitamin and trace-element supplementation on immune responses and infection in elderly subjects. Nutrition in Crohn disease. The influence of zinc status and malnutrition on immunological function in Crohn's disease.
Risk factors for intra-abdominal sepsis after surgery in Crohn's disease. Infections associated with tumor necrosis factor-alpha antagonists. Risk of infection during treatment with tumor necrosis factor-alpha inhibitors. Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease. Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis.
Fungal infections complicating tumor necrosis factor alpha blockade therapy. Risk of infectious complications in patients taking glucocorticosteroids. Glucocorticoid use, other associated factors, and the risk of tuberculosis. Meta-analysis: pre-operative infliximab treatment and short-term post-operative complications in patients with ulcerative colitis.
Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. Infectious complications of tumor necrosis factor-alpha antagonists. Listeria meningitis in a patient with Crohn's disease — a seldom, but clinically relevant adverse event of therapy with infliximab. Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.
Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease. Nonmelanoma skin cancer in inflammatory bowel disease: a review. Risk of nonmelanoma skin cancer with azathioprine use. Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease. A comparison of budesonide and mesalamine for active Crohn's disease.
International BudesonideMesalamine Study Group. Budesonide 9 mg is at least as effective as mesalamine 4. Aminosalicylates for induction of remission or response in Crohn's disease. Efficacy of 5-aminosalicylates in Crohn's disease: systematic review and meta-analysis. Crohn's disease, Management in adults, children and young people. Leitlinie Leitlinie Su C. Outcomes of placebo therapy in inflammatory bowel disease. Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebocontrolled trial with rifaximin.
Rifaximin-extended intestinal release induces remission in patients with moderately active Crohn's disease. A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. Randomized controlled trial of clarithromycin and ethambutol in the treatment of Crohn's disease.
Double blind, placebo controlled trial of metronidazole in Crohn's disease. Antibiotic therapy for treatment in relapse of intestinal Crohn's disease. A prospective randomized study. Metronidazole in Crohn's disease. A double blind cross-over clinical trial. Preliminary study of ciprofloxacin in active Crohn's disease. An antibiotic regimen for the treatment of active Crohn's disease: a randomized, controlled clinical trial of metronidazole plus ciprofloxacin.
Traditional corticosteroids for induction of remission in Crohn's disease. Combined budesonide and antibiotic therapy for active Crohn's disease: a randomized controlled trial. HLA-B27 related arthritis and bowel inflammation. Part 2. Ileocolonoscopy and bowel histology in patients with HLA-B27 related arthritis. Analysis of the therapeutic efficacy of different doses of budesonide in patients with active Crohn's ileocolitis depending on disease activity and localization.
Prolonged duration of response to infliximab in early but not late pediatric Crohn's disease. Response to infliximab is related to disease duration in paediatric Crohn's disease. Increased response and remission rates in short-duration Crohn's disease with subcutaneous certolizumab pegol: an analysis of PRECiSE 2 randomized maintenance trial data.
Patterns and operative treatment of recurrent Crohn's disease: a prospective longitudinal study. Safety and efficacy of strictureplasty for Crohn's disease: a systematic review and meta-analysis. Gastroduodenal Crohn's disease: medical management. Treatment of gastroduodenal Crohn's disease. Impact of different therapeutic regimens on the outcome of patients with Crohn's disease of the upper gastrointestinal tract.
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. A randomized, placebo-controlled trial of certolizumab pegol CDP for treatment of Crohn's disease. Certolizumab pegol for the treatment of Crohn's disease. Maintenance therapy with certolizumab pegol for Crohn's disease. Incidence and clinical significance of immunogenicity to infliximab in Crohn's disease: a critical systematic review.
Azathioprine or 6-mercaptopurine for inducing remission of Crohn's disease. Azathioprine for maintaining remission of Crohn's disease. Optimization of immunomodulatory treatment with azathioprine or 6-mercaptopurine in inflammatory bowel disease. Methotrexate for induction of remission in refractory Crohn's disease. Methotrexate: first-line or second-line immunomodulator? Methotrexate in patients with Crohn's disease after 6-mercaptopurine.
Efficacy of methotrexate in pediatric Crohn's disease: a French multicenter study. Role of methotrexate in the management of Crohn disease. Infliximab dose intensification in Crohn's disease. Dosage adjustment during long-term adalimumab treatment for Crohn's disease: clinical efficacy and pharmacoeconomics.
Häufige Hautkrankheiten im Kindesalter: Klinik - Diagnose - Therapie (German Edition): Medicine & Health Science Books @ rapyzure.tk Das Buch beschränkt sich bewusst auf die häufigsten Hauterkrankungen, die Häufige Hautkrankheiten im Kindesalter. Klinik — Diagnose — Therapie.
Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. Influence of trough serum levels and immunogenicity on long-term outcome of adalimumab therapy in Crohn's disease. Clinical utility of measuring infliximab and human anti-chimeric antibody concentrations in patients with inflammatory bowel disease.
The temporal evolution of antidrug antibodies in patients with inflammatory bowel disease treated with infliximab. Gut ; DOI: Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial. Certolizumab pegol in patients with moderate to severe Crohn's disease and secondary failure to infliximab. Effect of long-term low-dose prednisone on height velocity and disease activity in pediatric and adolescent patients with Crohn disease. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children.
Interventions for growth failure in childhood Crohn's disease. Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children. Colonic Crohn's disease in children does not respond well to treatment with enteral nutrition if the ileum is not involved. Budesonide versus prednisolone for the treatment of active Crohn's disease in children: a randomized, double-blind, controlled, multicentre trial.
A comparison of budesonide and prednisone for the treatment of active pediatric Crohn disease. Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study. The natural history of adult Crohn's disease in population-based cohorts. Predictive factors for a mild course of Crohn's disease. Anxiety and depression in patients with inflammatory bowel disease: comparisons with chronic liver disease patients and the general population. I: Impact of mucosal healing on the course of inflammatory bowel disease.
A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Effectiveness of an "half elemental diet" as maintenance therapy for Crohn's disease: A randomized-controlled trial. Supplementary enteral nutrition maintains remission in paediatric Crohn's disease. Active and passive smoking in childhood is related to the development of inflammatory bowel disease. Smoking and inflammatory bowel disease: a meta-analysis. Oral contraceptive use and smoking are risk factors for relapse in Crohn's disease.
Tobacco use is associated with accelerated clinical recurrence of Crohn's disease after surgically induced remission. Review article: smoking cessation as primary therapy to modify the course of Crohn's disease. Effects of cigarette smoking on the long-term course of Crohn's disease.
Effect of cigarette smoking on the course of Crohn's disease. Corticosteroids for maintenance of remission in Crohn's disease. DOI: Low dose steroids and clinical relapse in Crohn's disease: a controlled trial. Budesonide for maintenance of remission in Crohn's disease. Azathioprine or 6mercaptopurine for maintenance of remission in Crohn's disease.
A randomized, double-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine. Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease. Lancet ; 2: — Kamm MA. Review article: chronic active disease and maintaining remission in Crohn's disease.
Efficacy of azathioprine in the treatment of chronic active Crohn's disease: prospective one-year follow-up study. German Imurek Study Group. Methotrexate for maintenance of remission in Crohn's disease. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease.
Methotrexate in chronic active Crohn's disease: a double-blind, randomized, Israeli multicenter trial. Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials. Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease. Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis. Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease IBD in Germany: An online IBD registry.
Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's Disease. Systematic review: the potential influence of mesalazine formulation on maintenance of remission in Crohn's disease. Oral nutritional supplementation is effective in the maintenance of remission in Crohn's disease. Effect of early immunomodulator use in moderate to severe pediatric Crohn disease. Natural history of Crohn's disease in a population-based cohort from Cardiff — : a study of changes in medical treatment and surgical resection rates.
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. Early use of immunosuppressives or TNF antagonists for the treatment of Crohn's disease: time for a change. Gut ; — Rogler G. Top-down or step-up treatment in Crohn's disease? Clinical risk factors for complicated disease: how reliable are they?
Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort. Long term outcome of patients with active Crohn's disease exhibiting extensive and deep ulcerations at colonoscopy. Predictors for subsequent need for immunosuppressive therapy in early Crohn's disease. Advanced age is an independent risk factor for severe infections and mortality in patients given antitumor necrosis factor therapy for inflammatory bowel disease.
A prospective analysis of the incidence of and risk factors for opportunistic infections in patients with inflammatory bowel disease. Health care costs and their predictors of inflammatory bowel diseases in Germany. A systematic review and economic evaluation of the use of tumour necrosis factor-alpha TNF-alpha inhibitors, adalimumab and infliximab, for Crohn's disease. Infliximab plus azathioprine for steroid-dependent Crohn's disease patients: a randomized placebocontrolled trial.
Combining infliximab with methotrexate for the induction and maintenance of remission in refractory Crohn's disease: a controlled pilot study. Efficacy and safety of retreatment with anti-tumor necrosis factor antibody infliximab to maintain remission in Crohn's disease. Crohn's disease patients' riskbenefit preferences: serious adverse event risks versus treatment efficacy. Mercaptopurine treatment should be considered in azathioprine intolerant patients with inflammatory bowel disease. Adherence to thiopurine treatment in out-patients with Crohn's disease. Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial.
Gastroenterology ; DOI: Randomized controlled azathioprine withdrawal after more than two years treatment in Crohn's disease: increased relapse rate the following year. Azathioprine withdrawal in patients with Crohn's disease maintained on prolonged remission: a high risk of relapse. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease. Do patients consider postoperative maintenance therapy for Crohn's disease worthwhile?
In favour of prophylactic treatment for post-operative recurrence in Crohn's disease. The case against routine post-operative therapy for prevention of recurrence in Crohn's disease. Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery. Preventive therapy in postoperative Crohn's disease. Management of postoperative Crohn's disease. Maintenance of surgically induced remission of Crohn's disease.
Mesalazine as a maintenance treatment in Crohn's disease. Gut ; — Akobeng AK. Review article: the evidence base for interventions used to maintain remission in Crohn's disease. Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease.
Does it matter where you are hospitalized for inflammatory bowel disease? A nationwide analysis of hospital volume. Long-term outcomes following laparoscopically assisted versus open ileocolic resection for Crohn's disease. Is there any difference in recurrence rates in laparoscopic ileocolic resection for Crohn's disease compared with conventional surgery? A long-term, follow-up study. Crohn disease. Long-term effects of surgical treatment. Long-term follow-up in Crohn's disease. Mortality, morbidity, and functional status. Ileocolic resection for acute presentation of Crohn's disease of the ileum.
Long-term outcome after ileocecal resection for Crohn's disease. Recurrence after abdominal surgery for Crohn's disease: relationship to disease site and surgical procedure. Risk factors for surgical recurrence after ileocolic resection of Crohn's disease. Laparoscopic ileocolic resection versus infliximab treatment of distal ileitis in Crohn's disease: a randomized multicenter trial LIR! Health-related quality of life in patients with Crohn's disease: influence of surgical operation — a prospective trial. Perforating Crohn's ileitis: delay of surgery is associated with inferior postoperative outcome.
Early versus late surgery for ileocaecal Crohn's disease. Surgery in children with Crohn disease refractory to medical therapy. Colorectal cancer screening and surveillance in Crohn's colitis. Free perforation in Crohn's disease. Intraabdominal abscess in regional enteritis.
The clinical impact of preoperative percutaneous drainage of abdominopelvic abscesses in patients with Crohn's disease. Efficacy of different therapeutic options for spontaneous abdominal abscesses in Crohn's disease: are antibiotics enough?
Recurrent superficial lymphangitis after insect bites. Treating insect-bite hypersensitivity in horses with active vaccination against IL A Clinicopathologic Study of 10 Cases. Journal of clinical medicine, 4 6 In this sequel to The Inventor's Secret, Charlotte and her companions escape the British Empire, but they haven't left danger behind. Identification and implication of an allergenic PR protein from walnut in birch pollen associated walnut allergy.
Outcomes of Crohn's disease presenting with abdominopelvic abscess. Outcome of surgical versus percutaneous drainage of abdominal and pelvic abscesses in Crohn's disease. The outcome of initial percutaneous drainage versus surgical drainage for intra-abdominal abscesses in Crohn's disease. Incidence and microbiology of abdominal and pelvic abscess in Crohn's disease. Kalkulierte Antibiotikatherapie bei intraabdominellen Infektionen — Fallbeispiele und evidenzbasierte Therapieempfehlungen. Abscesses in Crohn's disease: outcome of medical versus surgical treatment.
Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Assessment of inflammatory and fibrotic stenoses in patients with Crohn's disease using contrast-enhanced ultrasound and computerized algorithm: a pilot study. The value of small bowel wall contrast enhancement after sulfur hexafluoride-filled microbubble injection to differentiate inflammatory from fibrotic strictures in patients with Crohn's disease.
Accuracy of imaging for predicting operative approach in Crohn's disease. Crohn's disease complicated by strictures: a systematic review. Systematic review: Endoscopic dilatation in Crohn's disease. Efficacy and safety of endoscopic balloon dilation of symptomatic intestinal Crohn's disease strictures.
Endoscopic dilation is an efficacious and safe treatment of intestinal strictures in Crohn's disease. The response of Crohn's strictures to endoscopic balloon dilation. Comparison of strictureplasty and endoscopic balloon dilatation for stricturing Crohn's disease — review of the literature. Comparison of conventional and nonconventional strictureplasties in Crohn's disease: a systematic review and meta-analysis. Strictureplasty vs resection in small bowel Crohn's disease: an evaluation of short-term outcomes and recurrence. Stapled versus handsewn methods for ileocolic anastomoses.
Recurrence of Crohn's disease after ileocolic resection is not affected by anastomotic type: results of a multicenter, randomized, controlled trial. Comparison of laparoscopic and open ileocecal resection for Crohn's disease: a metaanalysis. Laparoscopic surgery for Crohn's disease: a metaanalysis. Long-term surgical recurrence, morbidity, quality of life, and body image of laparoscopic-assisted vs.
Laparoscopy for recurrent Crohn's disease: how do the results compare with the results for primary Crohn's disease? Laparoscopic surgery for recurrent ileocolic Crohn's disease is as safe and effective as primary resection. Strictureplasty for large bowel stenosis in Crohn's disease: quality of life after surgical therapy. The effect of Crohn's disease on outcomes after restorative proctocolectomy. Risk factors for complications after bowel surgery in Korean patients with Crohn's disease.
Use of infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn's patients. Split stoma in resectional surgery of high-risk patients with ileocolonic Crohn's disease. Postoperative morbidity after bowel resections in patients with Crohn's disease: risk, management strategies, prevention. Preoperative steroid use and risk of postoperative complications in patients with inflammatory bowel disease undergoing abdominal surgery.
Biologic treatment or immunomodulation is not associated with postoperative anastomotic complications in abdominal surgery for Crohn's disease. Thiopurine therapy is associated with postoperative intra-abdominal septic complications in abdominal surgery for Crohn's disease. Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis. The risk of post-operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study.
Perianal Crohn's disease. Results of local surgical treatment. Treatment of fistulizing Crohn's disease. Gastroenterology ; — Solomon MJ. Fistulae and abscesses in symptomatic perianal Crohn's disease. Practice parameters for the management of perianal abscess and fistula-in-ano. Long-term outcome following loose-seton technique for external sphincter preservation in complex anal fistula.
Healing of perineal Crohn's disease with metronidazole. Treatment of cutaneous abscess: a double-blind clinical study. Treatment of acute abscesses by incision, curettage and primary suture without antibiotics: a controlled clinical trial. The treatment of acute superficial abscesses: a prospective clinical trial.
Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study. Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. Infliximab for the treatment of fistulas in patients with Crohn's disease. Long-term quality of life in patients with Crohn's disease and perianal fistulas: influence of fecal diversion. Surgical therapy of perianal Crohn's disease. Effect of fecal diversion alone on perianal Crohn's disease. Perianal Crohn disease: predictors of need for permanent diversion. Ann Surg ; — [Anonym].
American Gastroenterological Association medical position statement: perianal Crohn's disease. Surgical therapy of recurrent Crohn disease. Timing of surgery for enterovesical fistula in Crohn's disease: decision analysis using a time-dependent compartment model. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Vitamin B12 malabsorption in patients with limited ileal resection. Diagnosis and management of iron deficiency anemia in patients with IBD.
Soluble transferrin receptor-ferritin index is the most efficient marker for the diagnosis of iron deficiency anemia in patients with IBD. Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: a systematic review and meta-analysis.
Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study. Aktualisierte S3-Leitlinie — … Z Gastroenterol ; — mia in patients with inflammatory bowel disease—a randomized, controlled, open-label, multicenter study.
Intravenous iron-dextran: therapeutic and experimental possibilities. Diagnosis and treatment of vitamin B12 deficiency — an update. Ophthalmological aspects of IBD. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history.
Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study the IBSEN study. The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population-based study the IBSEN study.
Infliximab-induced lupus in Crohn's disease: a case report. Evidence and consensus based GKJR guidelines for the treatment of juvenile idiopathic arthritis. Exploring the differential diagnosis of joint complaints in pediatric patients with inflammatory bowel disease. Improvement of arthritis and arthralgia after treatment with infliximab Remicade in a German prospective, open-label, multicenter trial in refractory Crohn's disease. Opioid therapy for treating rheumatoid arthritis pain. Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease.
The gastrointestinal safety and effect on disease activity of etoricoxib, a selective cox-2 inhibitor in inflammatory bowel diseases. Safety of celecoxib in patients with ulcerative colitis in remission: a randomized, placebocontrolled, pilot study. The effect of treatment on radiological progression in rheumatoid arthritis: a systematic review of randomized placebo-controlled trials. Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of patients. Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register.
Annals of the rheumatic diseases ; — Heruntergeladen von: University of Pennsylvania Libraries. Induction of psoriasis with antiTNF agents in patients with inflammatory bowel disease: a report of 21 cases. Erythema nodosum: an evaluation of cases. Frequency, phenotype, outcome, and therapeutic impact of skin reactions following initiation of adalimumab therapy: experience from a consecutive cohort of inflammatory bowel disease patients.
Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Therapy Insight: pyoderma gangrenosum-old disease, new management. Pyoderma gangrenosum: a review and update on new therapies. A retrospective study of 12 cases of pyoderma gangrenosum: why we should avoid surgical intervention and what therapy to apply.